Capital Performance Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-25
Closed -$385 180
2024
Q3
$385 Buy
+25
New +$385 ﹤0.01% 2364